BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30125611)

  • 1. Lectin-based biosensors as analytical tools for clinical oncology.
    Silva MLS
    Cancer Lett; 2018 Nov; 436():63-74. PubMed ID: 30125611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin biosensors in cancer glycan biomarker detection.
    Silva MLS
    Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
    Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
    Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes.
    Cheng N; Du D; Wang X; Liu D; Xu W; Luo Y; Lin Y
    Trends Biotechnol; 2019 Nov; 37(11):1236-1254. PubMed ID: 31104858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer molecular markers: A guide to cancer detection and management.
    Nair M; Sandhu SS; Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluid future for liquid biopsies: Despite recent progress, most noninvasive cancer tests must still prove their mettle in the laboratory and the clinic.
    Nelson B
    Cancer Cytopathol; 2018 Dec; 126(12):963-964. PubMed ID: 30570835
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetics and Precision Oncology.
    Werner RJ; Kelly AD; Issa JJ
    Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Medicine Takes the Stage, Again!
    Tempero M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
    [No Abstract]   [Full Text] [Related]  

  • 10. Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery.
    Kim YS; Yoo HS; Ko JH
    Protein Pept Lett; 2009; 16(5):499-507. PubMed ID: 19442229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid biosensing tools for cancer biomarkers.
    Ranjan R; Esimbekova EN; Kratasyuk VA
    Biosens Bioelectron; 2017 Jan; 87():918-930. PubMed ID: 27664412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
    Saumet A; Lecellier CH
    Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
    Benz MR; Vargas HA; Sala E
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):1-10. PubMed ID: 26613872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation neuro-oncology.
    Weller M
    Eur J Cancer; 2018 Jun; 96():1-5. PubMed ID: 29656021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
    Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
    Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensors in clinical practice: focus on oncohematology.
    Fracchiolla NS; Artuso S; Cortelezzi A
    Sensors (Basel); 2013 May; 13(5):6423-47. PubMed ID: 23673681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine: CCO's vision, accomplishments and future plans.
    Guo J; Kamel-Reid S; Rutherford M; Hart J; Melamed S; Pollett A
    Healthc Q; 2015; 17 Spec No():41-3. PubMed ID: 25562133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Microfluidic and Biosensor Technologies for Improved Cancer Theranostics.
    Caballero D; Abreu CM; Reis RL; Kundu SC
    Adv Exp Med Biol; 2022; 1379():461-495. PubMed ID: 35761004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review on lectin-based electrochemical biosensors for clinically relevant carbohydrates and glycoconjugates.
    Abrantes-Coutinho VE; Santos AO; Moura RB; Pereira-Junior FN; Mascaro LH; Morais S; Oliveira TMBF
    Colloids Surf B Biointerfaces; 2021 Dec; 208():112148. PubMed ID: 34624598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.